SLCO1A2 Knockout HuH-7 Cell Line

The choice depends on whether you are studying SLCO1A2 (OATP1A2)'s role in drug uptake at the blood-brain barrier and intestine or its contributions to drug pharmacokinetics. The Knockout line is the standard tool for asking whether SLCO1A2 is required for cellular uptake of its substrates — including thyroid hormones, BSP, and many drugs subject to OATP1A2-mediated transport. Overexpression is useful for transport kinetics studies and inhibitor specificity testing. For pharmacokinetics research, the EDITGENE SLCO1A2 Knockout in Huh-7 provides a hepatocyte-derived background for studying transport biology, though SLCO1A2's principal physiological sites are intestine and brain endothelium rather than liver. The model is particularly useful for drug-drug interaction studies and OATP1A2 inhibitor characterization. Rescue with wild-type or transport-deficient SLCO1A2 enables mechanism and selectivity studies.

Primary applications: • Transport activity assays: cellular uptake of OATP1A2 substrates (BSP, thyroid hormones T3/T4, taurocholate) using radiolabeled tracers. • Drug uptake studies: clinically relevant OATP1A2 substrates including methotrexate, fexofenadine, and various drugs subject to OATP1A2-mediated transport. • Inhibitor specificity: critical genetic control for OATP1A2-targeted compounds and food-drug interaction studies (grapefruit, orange juice components). • Substrate-specific kinetic studies: rescue with wild-type SLCO1A2 in transport kinetics assays. EDITGENE recommends this model for researchers investigating OATP1A2 biology, drug transporter pharmacology, and blood-brain barrier transport mechanisms.

Yes. SLCO1A2 rescue experiments require attention to transporter topology: • Construct design: use a codon-modified SLCO1A2 sequence with a small C-terminal tag (FLAG, HA). SLCO1A2 has the canonical OATP 12-transmembrane architecture. • Surface expression validation: confirm plasma membrane localization before transport assays. • Polymorphism rescue: clinically relevant SLCO1A2 variants (e.g., R168C) can be introduced for pharmacogenomic studies in a controlled background. • Functional readout: rescue should restore cellular uptake of canonical OATP1A2 substrates (BSP, T3/T4, methotrexate) measured by appropriate detection methods. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.